Search
                    Parkinson's Disease Paid Clinical Trials in Colorado
A listing of 18  Parkinson's Disease  clinical trials  in Colorado  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            13 - 18 of 18
        
                The state of Colorado currently has 18 active clinical trials seeking participants for Parkinson's Disease research studies. These trials are conducted in various cities, including Denver, Aurora, Colorado Springs and Englewood. 
            
                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    
                
                                    Adaptive DBS to Offset STN Dysregulation During Exercise in PD
                                
            
            
        Recruiting
                            
            
                The investigators conduct a prospective study to evaluate the effects of exercise on Parkinson's Disease brain biomarkers detected with the PerceptTM PC neurostimulator.             
        
        
    Gender:
                ALL
            Ages:
                Between 20 years and 70 years
            Trial Updated:
                03/13/2025
            
            Locations: University of Colorado, Aurora, Colorado         
        
        
            Conditions: Parkinson Disease
        
            
        
    
                
                                    Study in Parkinson Disease of Exercise
                                
            
            
        Recruiting
                            
            
                This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with early stage Parkinson disease. 370 participants will be randomly assigned to 2 groups: 1)60-65% HRmax or 2)80-85% HRmax 4 times per week. The primary objective is to test whether the progression of the signs of Parkinson's disease is attenuated at 12 mon...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 40 years and 80 years
            Trial Updated:
                11/12/2024
            
            Locations: University of Colorado, Denver, Aurora, Colorado         
        
        
            Conditions: Parkinson Disease
        
            
        
    
                
                                    Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to investigate the effects of exercise rehabilitation on cognition and to evaluate slow wave sleep (SWS) as a biomarker and mediator of response to rehabilitation-induced improvement in cognitive performance among persons with Parkinson's disease (PwP), with the ultimate goal of maximizing rehabilitation efficacy at the individual level (i.e. precision rehabilitation).             
        
        
    Gender:
                ALL
            Ages:
                Between 45 years and 100 years
            Trial Updated:
                09/27/2024
            
            Locations: University of Colorado, Anschutz Medical Campus, Aurora, Colorado         
        
        
            Conditions: Parkinson Disease
        
            
        
    
                
                                    Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to learn if a Decision Aid can help patients with Parkinson's disease make a decision about undergoing Deep Brain Stimulation surgery. The main questions it aims to answer are:
* Is the Decision Aid acceptable to patients with Parkinson's disease considering Deep Brain Stimulation surgery?
* Does the decision aid improve decision quality (informed, value-based decision) and uncertainty about the decision?
Researchers will compare immediate use of the decision...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/04/2024
            
            Locations: University of Colorado Anschutz, Aurora, Colorado         
        
        
            Conditions: Parkinson Disease
        
            
        
    
                
                                    Abbott DBS Post-Market Study of Outcomes for Indications Over Time
                                
            
            
        Recruiting
                            
            
                The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                05/24/2024
            
            Locations: Colorado Neurodiagnostics, Littleton, Colorado  +1 locations         
        
        
            Conditions: Movement Disorders, Parkinson Disease, Essential Tremor, Tremor, Dystonia, Primary Dystonia, Secondary Dystonia
        
            
        
    
                
                                    NMT for Parkinson's Disease
                                
            
            
        Recruiting
                            
            
                Parkinson's Disease (PD) is defined by characteristic motor symptoms including slow movements, small movements, difficulty with movement initiation and disruptions in timing. Besides gross motor symptoms, fine motor impairments in PD cause difficulties with everyday tasks such as writing, self-care, and fine object manipulation. These activity limitations can lead to disability, social isolation, and a reduced quality of life. In a series of breakthrough studies Michael Thaut and colleagues deve...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 45 years and 85 years
            Trial Updated:
                01/02/2024
            
            Locations: University of Colorado Denver, Aurora, Colorado         
        
        
            Conditions: Parkinson Disease
        
            
        
    13 - 18 of 18
            